BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yu JW, Wu JG, Zheng LH, Zhang B, Ni XC, Li XQ, Jiang BJ. Influencing factors and clinical significance of the metastatic lymph nodes ratio in gastric adenocarcinoma. J Exp Clin Cancer Res. 2009;28:55. [PMID: 19393100 DOI: 10.1186/1756-9966-28-55] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Wu JG, Yu JW, Wu HB, Zheng LH, Ni XC, Li XQ, Du GY, Jiang BJ. Expressions and clinical significances of c-MET, p-MET and E2f-1 in human gastric carcinoma. BMC Res Notes. 2014;7:6. [PMID: 24393368 DOI: 10.1186/1756-0500-7-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
2 Zhang YF, Shi J, Yu HP, Feng AN, Fan XS, Lauwers GY, Mashimo H, Gold JS, Chen G, Huang Q. Factors predicting survival in patients with proximal gastric carcinoma involving the esophagus. World J Gastroenterol 2012; 18(27): 3602-3609 [PMID: 22826627 DOI: 10.3748/wjg.v18.i27.3602] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
3 Kim DH, Kim SM, Hyun JK, Choi MG, Noh JH, Sohn TS, Bae JM, Kim S. Changes in postoperative recurrence and prognostic risk factors for patients with gastric cancer who underwent curative gastric resection during different time periods. Ann Surg Oncol 2013;20:2317-27. [PMID: 23677605 DOI: 10.1245/s10434-012-2700-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
4 Yu JW, Wu JG, Tajima Y, Li XQ, Du GY, Zheng LH, Zhang B, Ni XC, Jiang BJ. Study on lymph node metastasis correlated to lymphangiogenesis, lymphatic vessel invasion, and lymph node micrometastasis in gastric cancer. J Surg Res. 2011;168:188-196. [PMID: 20189585 DOI: 10.1016/j.jss.2009.10.030] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
5 Wei B, Song Y, Zhang Y, Hu M. microRNA-449a functions as a tumor-suppressor in gastric adenocarcinoma by targeting Bcl-2. Oncol Lett. 2013;6:1713-1718. [PMID: 24260067 DOI: 10.3892/ol.2013.1609] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
6 Tavares A, Viveiros F, Maciel J, Dinis-Ribeiro M. Conventional clinical and pathological features fail to accurately predict recurrence in patients with gastric cancer staged N0. Eur J Gastroenterol Hepatol 2015;27:425-9. [PMID: 25874516 DOI: 10.1097/MEG.0000000000000307] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
7 Wu JG, Yu JW, Lu RQ, Wang SL, Ni XC, Zheng LH, Jiang BJ. Preliminary Study on the Expression and the Clinical Significance of CD133 in Peripheral Blood of Patients with Gastric Adenocarcinoma. ISRN Gastroenterol 2014;2014:245329. [PMID: 24653835 DOI: 10.1155/2014/245329] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
8 Park SW, Lee HL, Ju YW, Jun DW, Lee OY, Han DS, Yoon BC, Choi HS, Hahm JS. Inverse association between visceral obesity and lymph node metastasis in gastric cancer. J Gastrointest Surg 2015;19:242-50. [PMID: 25338660 DOI: 10.1007/s11605-014-2682-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
9 Xiao W, Bao ZX, Zhang CY, Zhang XY, Shi LJ, Zhou ZT, Jiang WW. Upregulation of miR-31* is negatively associated with recurrent/newly formed oral leukoplakia. PLoS One 2012;7:e38648. [PMID: 22719913 DOI: 10.1371/journal.pone.0038648] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 4.7] [Reference Citation Analysis]
10 Yao Q, Gu A, Wang Z, Xue Y. MicroRNA-144 functions as a tumor suppressor in gastric cancer by targeting cyclooxygenase-2. Exp Ther Med 2018;15:3088-95. [PMID: 29456712 DOI: 10.3892/etm.2018.5763] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
11 Zhang X, Yang J, Huang Q, Lyu J. Prognostic factors in patients with gastric adenocarcinoma using competing-risk analysis: a study of cases in the SEER database.Scand J Gastroenterol. 2019;54:1015-1021. [PMID: 31382800 DOI: 10.1080/00365521.2019.1649456] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
12 Huang Q. Carcinoma of the gastroesophageal junction in Chinese patients. World J Gastroenterol 2012; 18(48): 7134-7140 [PMID: 23326117 DOI: 10.3748/wjg.v18.i48.7134] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
13 Xiao LB, Yu JX, Wu WH, Xu FF, Yang SB. Superiority of metastatic lymph node ratio to the 7th edition UICC N staging in gastric cancer. World J Gastroenterol 2011; 17(46): 5123-5130 [PMID: 22171148 DOI: 10.3748/wjg.v17.i46.5123] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
14 Yu JW, Zhang P, Wu JG, Wu SH, Li XQ, Wang ST, Lu RQ, Ni XC, Jiang BJ. Expressions and clinical significances of CD133 protein and CD133 mRNA in primary lesion of gastric adenocacinoma. J Exp Clin Cancer Res 2010;29:141. [PMID: 21054902 DOI: 10.1186/1756-9966-29-141] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]